Showing results (21-30 of 136) with videos related to
Sort By:
Pageof 14
Acta Haematologica|March 3, 2024
Primary Nodal Epstein-Barr Virus-Positive T-Cell/NK-Cell Lymphoma: Real-World ExperienceDae-Ho Choi, Sang Eun Yoon, Junhun Cho, et al.Clinical Lymphoma, Myeloma & Leukemia|August 22, 2022
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell LymphomaSang Eun Yoon, Junhun Cho, Yeon Jeong Kim, et al.BMC Cancer|August 31, 2021
Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencingJunhun Cho, Sang Eun Yoon, Seok Jin Kim, et al.Leukemia & Lymphoma|March 3, 2025
Determination of the appropriate chemotherapy for patients aged 80 years or older with diffuse large B cell lymphomaMin Jung Kim, Junhun Cho, Won Seog Kim, et al.Cancer Medicine|September 14, 2023
Differences in mutational signature of diffuse large B-cell lymphomas according to the primary organHyun-Hee Koh, Sang Eun Yoon, Seok Jin Kim, et al.Cancer Management and Research|September 29, 2021
Imaging Features and Prognostic Value of FDG PET/CT in Patients with Intravascular Large B-Cell LymphomaChae Hong Lim, Sang Eun Yoon, Won Seog Kim, et al.Blood Advances|February 2, 2026
Long-term outcomes of 40Gy CCRT with weekly cisplatin and systemic chemotherapy in limited-stage ENKTLSang Eun Yoon, Dongryul Oh, Gwanghui Ryu, et al.International Journal of Hematology|August 22, 2025
Clinical outcomes of tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma: insights from a single-center studySang Eun Yoon, Junhun Cho, Duck Cho, et al.Seminars in Hematology|February 22, 2023
Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical managementEric Tse, Christopher P Fox, Alexander Glover, et al.Blood|May 2, 2024
CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysisJinchul Kim, Jinhyun Cho, Moon Hee Lee, et al.Pageof 14